| Date Filed | Type | Description |
| 03/02/2023 |
4
| Eckelman Brendan P. (Chief Scientific Officer) has filed a Form 4 on Inhibrx, Inc.|
Txns:
| Sold 39,600 shares
@ $24.2007, valued at
$958.3k
Sold 400 shares
@ $24.7075, valued at
$9.9k
|
|
| 03/01/2023 |
4
| Lappe Mark (CEO) has filed a Form 4 on Inhibrx, Inc.|
Txns:
| Sold 60 shares
@ $25.0208, valued at
$1.5k
|
|
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/24/2023 |
4
| Lappe Mark (CEO) has filed a Form 4 on Inhibrx, Inc.|
Txns:
| Sold 21,665 shares
@ $25.3572, valued at
$549.4k
Sold 4,272 shares
@ $25.71, valued at
$109.8k
Sold 63 shares
@ $26.1127, valued at
$1.6k
|
|
| 01/23/2023 |
4
| Kayyem Jon Faiz (Director) has filed a Form 4 on Inhibrx, Inc.|
Txns:
| Sold 9,500 shares
@ $25.2631, valued at
$240k
|
|
| 01/04/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/22/2022 |
4
| Kayyem Jon Faiz (Director) has filed a Form 4 on Inhibrx, Inc.|
Txns:
| Sold 7,541 shares
@ $26.8653, valued at
$202.6k
Sold 1,959 shares
@ $27.6099, valued at
$54.1k
|
|
| 12/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/18/2022 |
4
| Lappe Mark (CEO) has filed a Form 4 on Inhibrx, Inc.|
Txns:
| Sold 8,981 shares
@ $28.6626, valued at
$257.4k
Sold 14,006 shares
@ $29.9245, valued at
$419.1k
Sold 2,892 shares
@ $30.8055, valued at
$89.1k
Sold 121 shares
@ $31.5071, valued at
$3.8k
|
|
| 10/12/2022 |
4
| VIKING GLOBAL INVESTORS LP (10% Owner) has filed a Form 4 on Inhibrx, Inc.|
Txns:
| Bought 1,000,000 shares
@ $29.9999, valued at
$30M
Bought 333,333 shares
@ $29.9999, valued at
$10M
|
|
| 10/05/2022 |
4
| Eckelman Brendan P. (Chief Scientific Officer) has filed a Form 4 on Inhibrx, Inc.|
Txns:
| Sold 1,448 shares
@ $24.6688, valued at
$35.7k
Sold 6,207 shares
@ $26.0614, valued at
$161.8k
Sold 11,136 shares
@ $26.7764, valued at
$298.2k
Sold 4,262 shares
@ $27.7566, valued at
$118.3k
Sold 5,954 shares
@ $28.9713, valued at
$172.5k
Sold 10,893 shares
@ $29.6798, valued at
$323.3k
Sold 100 shares
@ $30.52, valued at
$3.1k
|
|
| 09/14/2022 |
4
| Eckelman Brendan P. (Chief Scientific Officer) has filed a Form 4 on Inhibrx, Inc.|
Txns:
| Gifted 160,000 shares
@ $0
Gifted 80,000 shares
@ $0
Gifted 80,000 shares
@ $0 |
|
| 09/07/2022 |
4
| Eckelman Brendan P. (Chief Scientific Officer) has filed a Form 4 on Inhibrx, Inc.|
Txns:
| Sold 37,507 shares
@ $14.857, valued at
$557.2k
Sold 2,493 shares
@ $15.6567, valued at
$39k
|
|
| 08/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/02/2022 |
4
| Kayyem Jon Faiz (Director) has filed a Form 4 on Inhibrx, Inc.|
Txns:
| Gifted 118,500 shares
@ $0
Gifted 25,000 shares
@ $0 |
|
| 07/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/07/2022 |
4
| Eckelman Brendan P. (Chief Scientific Officer) has filed a Form 4 on Inhibrx, Inc.|
Txns:
| Sold 400 shares
@ $25.04, valued at
$10k
|
|
| 01/25/2022 |
4
| Deck Kelly (CFO) has filed a Form 4 on Inhibrx, Inc.|
Txns:
| Granted 20,000 options to buy
@ $34.16, valued at
$683.2k
|
|
| 12/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/29/2021 |
3
| Vuori Kristiina MD (Director) has filed a Form 3 on Inhibrx, Inc. |
| 06/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|